Skip to main content

Table 11 Model results when frequency and duration of relapses are increased by 10%

From: Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: A cost effectiveness study

 

Paliperidone ER

Olanzapine

Risperidone

Quetiapine

Ziprasidone

Aripiprazole

+10% in frequency of relapses:

Cost (€)

7.344

7.397

7.373

8.678

8.171

8.070

Effectiveness

263.2

262.9

255.6

250.2

247.9

250.1

+10% in duration of relapses:

Cost (€)

7.259

7.312

7.282

8.583

8.074

7.975

Effectiveness

263.2

262.9

255.6

250.2

247.9

250.1